- Home
- CATX vs OPY Comparison
CATX vs OPY Comparison
Compare CATX & OPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- OPY
- Stock Information
- Founded
- CATX 1983
- OPY 1881
- Country
- CATX United States
- OPY United States
- Employees
- CATX N/A
- OPY N/A
- Industry
- CATX Medical/Dental Instruments
- OPY Investment Bankers/Brokers/Service
- Sector
- CATX Health Care
- OPY Finance
- Exchange
- CATX Nasdaq
- OPY Nasdaq
- Market Cap
- CATX 782.7M
- OPY 666.7M
- IPO Year
- CATX N/A
- OPY N/A
- Fundamental
- Price
- CATX $3.44
- OPY $68.90
- Analyst Decision
- CATX Strong Buy
- OPY
- Analyst Count
- CATX 9
- OPY 0
- Target Price
- CATX $17.25
- OPY N/A
- AVG Volume (30 Days)
- CATX 1.2M
- OPY 24.4K
- Earning Date
- CATX 02-12-2025
- OPY 01-31-2025
- Dividend Yield
- CATX N/A
- OPY 1.04%
- EPS Growth
- CATX N/A
- OPY 83.00
- EPS
- CATX N/A
- OPY 6.42
- Revenue
- CATX $1,557,000.00
- OPY $1,280,442,000.00
- Revenue This Year
- CATX N/A
- OPY N/A
- Revenue Next Year
- CATX N/A
- OPY N/A
- P/E Ratio
- CATX N/A
- OPY $10.74
- Revenue Growth
- CATX N/A
- OPY 7.32
- 52 Week Low
- CATX $2.70
- OPY $36.93
- 52 Week High
- CATX $19.10
- OPY $70.25
- Technical
- Relative Strength Index (RSI)
- CATX 41.92
- OPY 67.54
- Support Level
- CATX $3.02
- OPY $61.76
- Resistance Level
- CATX $3.74
- OPY $68.28
- Average True Range (ATR)
- CATX 0.26
- OPY 1.42
- MACD
- CATX 0.16
- OPY 0.27
- Stochastic Oscillator
- CATX 60.90
- OPY 94.33
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
About OPY Oppenheimer Holdings Inc. (DE)
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has three segments: private client, asset management, and capital markets. The Private Client segment, commissions and a proportionate amount of fee income earned on assets under management ("AUM"), net interest earnings on client margin loans and cash balances, fees from money market funds, and custodian fees. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.